American Pharmacy News
  • State Issues
  • Regulatory
  • Federal Issues
  • Industry
  • Innovation
  • Directory
  • State Issues
  • Regulatory
  • Federal Issues
  • Industry
  • Innovation
  • Directory
  • Home
  • »
  • Organizations

Organizations

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

Csl Behring


Cumberland Pharmaceuticals


Cvs Health


Daiichi Sankyo, Inc.


Del Mar Pharmaceuticals


Directrx


Drug Channels


Eisai


Eli Lilly And Company


Emd Millipore


Emd Serono, Inc.


Encountercare Solutions


Express Scripts


Fresenius Kabi


Fresenius Medical Care


Genentech, Inc


Generic Pharmaceutical Association


Gilead Sciences, Inc Hq


Glaxosmithkline


Greatbatch Inc.


  • «
  • 1
  • 2
  • 3 (current)
  • 4
  • 5
  • ...
  • 8
  • 9
  • »
Trending

Diana Harshbarger, U.S. Representative for Tennessee's 1st District

Rep. Harshbarger calls for PBM transparency, oversight: 'It’s time to shine a light on their shady practices'

Sally Pipes, President & CEO of Pacific Research Institute

Pacific Research Institute CEO Pipes on 340B program: It 'has become a major revenue stream for large hospital systems'

Elise Shutzer, Vice President of Public Affairs at PhRMA

PhRMA launches 'Goldmine: Spa Day' campaign targeting 340B hospital drug pricing program

Ted Okon, MBA, Executive Director, Community Oncology Alliance

Community Oncology Alliance Executive Director Okon on 340B: ‘Expanding participation in a flawed program isn’t reform’

Paul Gigot, Editor-in-chief, Wall Street Journal

WSJ Editorial Board says 340B program has been exploited following North Dakota ruling

Copyright © 2026 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up